Internal Medicine
Online ISSN : 1349-7235
Print ISSN : 0918-2918
ISSN-L : 0918-2918
CASE REPORTS
Hepatocellular Carcinoma in a Patient with Hereditary Hemorrhagic Telangiectasia
Kazuhiko MoriiRiku UematsuTakeharu YamamotoShinichiro NakamuraHiroaki OkushinNoriyuki NishiwakiTakanori WatanabeKyohei KaiShiso Sato
Author information
JOURNAL OPEN ACCESS

2018 Volume 57 Issue 24 Pages 3545-3549

Details
Abstract

A 76-year-old woman with hereditary hemorrhagic telangiectasia (HHT) showed elevated serum hepatobiliary enzyme levels, and abdominal imaging studies revealed a hepatic tumor. Her serum alpha-fetoprotein level was 759.5 ng/mL. A pathological examination after hepatectomy confirmed a diagnosis of hepatocellular carcinoma (HCC). An examination of the surrounding liver revealed dilated vessels and thickened endothelial cells without inflammations. HHT patients without other risk factors (like this patient) reportedly have a lower incidence of common cancers, including HCC, in comparison to the unaffected population. One intriguing hypothesis that might explain the hepatocarcinogenesis in this situation is the ischemic liver cirrhosis theory, which suggests that chronic ischemia may cause parenchymal strain and promote inappropriate hepatocyte proliferation.

Content from these authors
© 2018 by The Japanese Society of Internal Medicine
Previous article Next article
feedback
Top